New discoveries reported at ICRS symposium highlight CBD's potential for treating anxiety, cancer, heart disease, substance abuse, brain injuries, and more.
BY MARTIN A. LEE ON AUGUST 06, 2019
‘‘The 29th annual International Cannabinoid Research Society (ICRS) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine.
Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data.
Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinical trial” assessing the impact of a high-CBD, low-THC sublingual tincture in patients who experience moderate anxiety. None of the participants had been using any cannabinoid-based products prior to this study.
Preliminary data “suggests significant improvement following four weeks of treatment when compared to baseline,” Gruber noted. “Specifically, findings suggest that the use of a custom-formulated, whole plant-derived high CBD sublingual tincture results in less severe anxiety and fewer anxiety-related symptoms.”
After the completion of this open-label trial, Gruber intends to undertake a double-blind, placebo-controlled experiment that will generate “empirically sound data regarding the efficacy of sublingual CBD for anxiety.’’’’
ICRS 2019: CBD FOR ANXIETY, CANCER, HEART DISEASE, ADDICTION...
New discoveries reported at ICRS symposium highlight CBD's potential for treating anxiety, cancer, heart disease, substance abuse, brain injuries, and more. READ HERE
HOW CBD WORKS
Learn how CBD works with your body's endocannabinoid system. READ HERE
THE ENDOCANNABINOID SYSTEM
The ECS is a biochemical communication system in the human body, which plays a crucial role in regulating our physiology, mood, and everyday experience. READ HERE